Drawbacks of these studies [25, 26] include limited follow up on ART, majority of incident TB cases occurring in first 6 months post ART, all patients with symptoms not actively investigated for TB, non-availability of time updated CD4 count and viral load values and nonuse of culture or molecular methods for TB diagnosis. The gene discussed is CD4; the disease is tuberculosis.